Heron Therapeutics | 当期純利益





当期純利益 変化する 日付
ALKERMES USD 82.76M 4.34M 2025-09
Alnylam Pharmaceuticals USD 251.08M 317.36M 2025-09
Amarin USD -7.74M 6.4M 2025-09
ANI Pharmaceuticals USD 26.27M 18.13M 2025-09
Anika Therapeutics USD -4.87M 16.99M 2025-03
Arrowhead Research USD 30.81M 54.56M 2025-12
Eisai JPY 17.18B 7.02B 2025-12
Esperion Therapeutics USD -29.52M 32.4M 2024-09
GlaxoSmithKline GBP 636M 1.38B 2025-12
Heron Therapeutics USD -4.85M 4.39M 2024-09
Insmed USD -370.02M 48.34M 2025-09
Ligand Pharmaceuticals USD 117.27M 112.43M 2025-09
Merck USD 2.96B 2.82B 2025-12
Nektar Therapeutics USD -37.06M 15.31M 2024-09
Neurocrine Biosciences USD 209.5M 102M 2025-09
Omeros USD -32.23M 23.81M 2024-09
Pacira USD 5.43M 10.28M 2025-09
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Surmodics USD -11.54M 3.99M 2024-09
Ultragenyx Pharmaceutical USD -180.41M 65.46M 2025-09
Veracyte USD 19.14M 20.12M 2025-09
Vertex Pharmaceuticals USD 1.08B 50M 2025-09


Heron Therapeutics 当期純利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Feb 2026.